cycloheximide has been researched along with Apolipoprotein B-100, Familial Defective in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berge, KE; Holla, ØL; Kulseth, MA; Leren, TP; Ranheim, T | 1 |
| Harada-Shiba, M; Tajima, S; Yamamoto, A | 1 |
| Betteridge, DJ; Galton, DJ; Krone, W | 1 |
3 other study(ies) available for cycloheximide and Apolipoprotein B-100, Familial Defective
| Article | Year |
|---|---|
Nonsense-mediated decay of human LDL receptor mRNA.
Topics: Blotting, Western; Cell Transformation, Viral; Cells, Cultured; Codon, Nonsense; Cycloheximide; Flow Cytometry; Herpesvirus 4, Human; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lymphocytes; Polymerase Chain Reaction; Protein Biosynthesis; Protein Synthesis Inhibitors; Receptors, LDL; RNA Stability; RNA, Messenger | 2009 |
Response of 3-hydroxy-3-methylglutaryl CoA reductase to l-triiodothyronine in cultured fibroblasts from FH homozygotes.
Topics: Cells, Cultured; Cycloheximide; Dactinomycin; Fibroblasts; Homozygote; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Receptors, LDL; Skin; Triiodothyronine | 1995 |
Mechanism of regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by low density lipoprotein in human lymphocytes.
Topics: Cholesterol; Cycloheximide; Deoxyadenosines; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemia Type II; In Vitro Techniques; Lipoproteins, LDL; Lymphocytes; RNA, Messenger | 1979 |